Important: The content on en-newself.com is provided for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified, licensed healthcare provider before starting any medication, weight-loss program, or treatment.
Not Medical Advice
en-newself.com is a consumer review and educational website — not a medical clinic, pharmacy, telehealth provider, or licensed healthcare service. Nothing on this site creates a patient-provider relationship or substitutes for the professional judgment of a licensed physician. Do not start, stop, or change any medical treatment based solely on information found on this site.
Compounded Medications Are Not FDA-Approved
The NewSelf GLP-1 program dispenses compounded semaglutide and compounded tirzepatide — not the FDA-approved brand-name medications Ozempic, Wegovy, Mounjaro, or Zepbound. The FDA has not evaluated NewSelf's specific compounded formulations for safety, efficacy, or quality before they are marketed or dispensed. Compounding is legally authorized under specific conditions (including active drug shortage periods), but carries different regulatory requirements than FDA-approved pharmaceutical manufacturing.
Individual Results Vary
Clinical efficacy figures cited on this site — such as 14.9% average weight loss with semaglutide (STEP-1) or 22.5% with tirzepatide (SURMOUNT-1) — represent population-level averages from controlled clinical trials under medical supervision. Individual outcomes on the NewSelf program will vary significantly based on adherence, diet quality, physical activity, starting weight, prescribed dose, metabolic factors, and clinical monitoring. These figures are not guarantees of individual outcome and are not promises made by en-newself.com or by NewSelf.
FDA Warning
The FDA issued a warning letter to NewSelf LLC in February 2026 regarding misleading labeling and marketing claims. This is documented on our site. We recommend verifying NewSelf's current regulatory compliance status before enrolling. See our FDA warning explainer.
Seek Professional Medical Advice
Before beginning any GLP-1 weight-loss program — whether through NewSelf or any other provider — discuss your complete health history, current medications, and treatment goals with a licensed healthcare provider who knows your full medical record. If you experience adverse effects from any medication, contact a healthcare provider or emergency services immediately.